Georgetown Lombardi Survivorship Research Initiative Seminar Series: “Addressing Disparities in Genomic Care for Hereditary Cancer”

The Georgetown Lombardi Survivorship Research Initiative works to optimize cancer survivorship across the lifespan and ensure equity for patients of every race, ethnicity, gender and socially determined status. This seminar series will invite scientists from Georgetown and outside institutions to present their research. It will also provide a forum in which individuals may present work in progress to receive meaningful feedback from a multidisciplinary audience.

Anita Kinney, PhD, RN, FAAN, FABMR
Professor, Department of Biostatistics and Epidemiology, School of Public Health
Director, Center for Cancer Health Equity, School of Public Health
Associate Director for Cancer Health Equity and Engagement, Rutgers Cancer Institute of New Jersey

presents

“Addressing Disparities in Genomic Care for Hereditary Cancer”

Meet the Professor:
Dr. Kinney will speak from 10 – 11 a.m. Immediately following the SRI seminar, there will be a 30-minute Meet the Professor session, which will provide attendees an opportunity to engage in Q&A and discuss specific research subjects with Dr. Kinney.

About the Speaker:

Anita Kinney is a professor in the Department of Biostatistics and Epidemiology and director of the Center for Cancer Health Equity at the School of Public Health. She also serves as the associate director for cancer health equity and engagement at Rutgers Cancer Institute of New Jersey and director of ScreenNJ, a statewide cancer prevention and screening program. In these roles, Kinney seeks to advance cancer health equity in cancer prevention and care delivery through community partnerships and engagement, outreach, and a team science approach. Kinney has sustained research funding by the National Institutes of Health for nearly 30 years with a focus on cancer prevention, community and clinical genetics, and survivorship. Kinney’s research program is internationally recognized for studying and reducing cancer health disparities and translating genomic discoveries into clinical and public health practice. Her research brings a combination of behavioral science, clinical, and epidemiologic perspectives to address unsolved cancer problems in diverse populations and settings.